Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Scientific Reports|February 2, 2017
Computational imaging reveals shape differences between normal and malignant prostates on MRIMirabela Rusu, Andrei S Purysko, Sadhna Verma, et al.The Journal of Urology|December 12, 2019
The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate BiopsiesAmer Amin, Matthijs J Scheltema, Ron Shnier, et al.The Prostate|January 10, 2018
Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancerHui-Ming Lin, Brian Y Lee, Lesley Castillo, et al.Journal of Magnetic Resonance Imaging : JMRI|February 23, 2018
Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findingsAhmad Algohary, Satish Viswanath, Rakesh Shiradkar, et al.Journal of Magnetic Resonance Imaging : JMRI|December 20, 2016
Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional studyShoshana B Ginsburg, Ahmad Algohary, Shivani Pahwa, et al.Urology|July 8, 2022
Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node DissectionHilda A de Barros, Sebastiaan Remmers, Henk B Luiting, et al.Genome Medicine|August 31, 2022
Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic driversTingting Gong, Weerachai Jaratlerdsiri, Jue Jiang, et al.Cancers|May 13, 2020
The Impact of Whole Genome Data on Therapeutic Decision-Making in Metastatic Prostate Cancer: A Retrospective AnalysisMegan Crumbaker, Eva K F Chan, Tingting Gong, et al.BJU International|August 5, 2024
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation - IRE-IMMUNO studyBart Geboers, Matthijs J Scheltema, Jason Jung, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 25, 2010
Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkersJames Devaney, Clare Stirzaker, Wenjia Qu, et al.Pageof 6